Flu drugs are a new clinical trial that successfully causes fever

International researchers have just announced that they have successfully tested the first phase of a new, extremely effective and safe anti-influenza drug, radavirsen.

According to a study published in the Journal of Clinical Pharmacology, a total of 56 people who have been clinically tested with radavirsen drugs , belonging to the antisense oligomer strain are able to block the production and development of influenza virus proteins.

74% of people who received the drug radavirse were safe, the flu improved completely

"This is the first time that the radavirsen drug of the antisense oligomer strain has been shown to be easily tolerated, safe, and has excellent pharmacokinetic ability to treat influenza A," the researchers wrote .

Previously, scientists also screened 66 healthy people, 56 people directly participated in the study from mid-2013 to 2015, each dose was vaccinated against flu from 0.5 to 8mg, the rest is a placebo.

The initial results showed that 74% of people who received the drug radavirse were safe, the flu improved completely, but with 94% of the placebo group, 94% did not get the flu, or slowed down by self-elimination.

In parallel, a new sideline study showed that the major side effects of radavirsen were headache and proteinuria.

In general, the researchers confirmed that radavirsen was thought to be very safe and well tolerated by the majority of the study participants, recommending that other tests be conducted to test effectiveness. Of this drug further in the treatment for influenza patients.